Translate this page into:
Fellow eye’s revenge: Navigating sympathetic ophthalmia following penetrating keratoplasty
-
Received: ,
Accepted: ,
How to cite this article: Pani S, Sohail JM, Afreen SA. Fellow eye’s revenge: Navigating sympathetic ophthalmia following penetrating keratoplasty. J Ophthalmic Res Pract. 2026;4:60-3. doi: 10.25259/JORP_6_2026
Abstract
Sympathetic ophthalmia (SO) is a rare bilateral granulomatous uveitis that may occur following penetrating ocular injury or surgery. We report a 48-year-old man who developed SO in the left eye 3 weeks after therapeutic penetrating keratoplasty with cataract extraction for fungal keratitis in the right eye. He presented with decreased vision and floaters, and multimodal imaging, including optical coherence tomography, fundus fluorescein angiography, and fundus autofluorescence, demonstrated exudative retinal detachment with characteristic posterior segment findings. Prompt treatment with intravenous methylprednisolone followed by tapering oral corticosteroids and mycophenolate mofetil resulted in complete resolution of inflammation and subretinal fluid, with improvement of best-corrected visual acuity to 0.2 logMAR in both eyes at 6 months and no recurrence. This case highlights the importance of maintaining a high index of suspicion for SO after therapeutic penetrating keratoplasty and emphasizes that early diagnosis and aggressive immunosuppressive therapy can preserve vision.
Keywords
Exudative retinal detachment
Fellow eye
Panuveitis
Sympathetic ophthalmia
INTRODUCTION
Sympathetic ophthalmia (SO) represents a rare, bilateral granulomatous panuveitis that targets the uveal tract, usually sparked by trauma or surgery to one eye (the inciting eye), prompting an autoimmune attack on the uninjured fellow eye (sympathizing eye).[1-5]
Clinically, it typically emerges gradually with symptoms including vision blurring, light sensitivity, ocular ache, and redness, often featuring episodes of worsening and improvement.
Pathologically, the condition involves widespread or clustered infiltration of the uvea by lymphocytes and epithelioid cells, occasionally forming distinctive Dalen–Fuchs nodules in the choroid.[6]
CASE REPORT
A 48-year-old male presented with decreased vision and floaters in the left eye (LE), 3 weeks after undergoing TPK with extracapsular cataract extraction (for a cataractous lens) in the right eye (RE) due to a fungal corneal ulcer. Visual acuity was hand motions positive in the RE and counting fingers at counting fingers distance in the LE. Slit-lamp examination of the RE showed a full-thickness corneal graft secured with multiple interrupted 10-0 nylon sutures; the graft was hazy and edematous with dense fibrinous exudate and pupillary membrane in the anterior chamber [Figure 1]. The LE had 1+ cells in the anterior chamber and a clear lens. Dilated fundus examination of the LE revealed exudative retinal detachment (RD). Wide-field fundus photography showed green–yellow retinal expanse indicative of serous exudative RD, with subretinal fluid causing retinal thickening and shifting; a darker central foveal shadow suggested shallow detachment [Figure 2]. Fundus autofluorescence demonstrated multiple patchy hyper- and hypo-autofluorescent areas at the posterior pole, corresponding to retinal pigment epithelium (RPE) disturbance from serous RD and inflammation, consistent with granulomatous choroidal involvement [Figure 3]. Optical coherence tomography (OCT) confirmed serous (exudative) RD with hyporeflective subretinal fluid and undulating/ wavy RPE/outer retinal layers due to underlying choroidal inflammation [Figure 4]. Fundus fluorescein angiography showed multiple pinpoint hyperfluorescent leaks at the RPE level in early phases; progressive dye pooling in serous RD areas in late phases; disc hyperfluorescence (leakage) due to inflammation; and diffuse choroidal leakage with mottled hyperfluorescence indicating active choroiditis [Figure 5].





Systemic corticosteroid therapy was initiated with intravenous methylprednisolone at a dose of 1 mg/kg/day for 3 days, followed by oral prednisolone at 1.5 mg/kg/day, tapered over 3 months. Mycophenolate mofetil (1 g twice daily) was added concurrently as a steroid-sparing agent. Following treatment, the exudative RD resolved, fluorescein angiographic leakage subsided, and best-corrected visual acuity in the LE improved to 0.2 logMAR.
DISCUSSION
SO following therapeutic penetrating keratoplasty (TPK) is a rare but potentially vision-threatening complication, attributed to significant uveal tissue exposure and immune sensitization in an already inflamed eye. Early systemic immunosuppression is crucial to prevent irreversible visual loss, highlighting the need for close post-operative monitoring of the fellow eye.[7]
In the present case, SO developed 3 weeks after TPK for fungal keratitis, presenting as exudative RD in the fellow eye without significant anterior segment inflammation. This posterior segment–predominant presentation can delay diagnosis if classical anterior uveitis signs are absent. Multimodal imaging aided early detection, and prompt treatment with systemic corticosteroids and mycophenolate mofetil resulted in complete anatomical resolution and significant visual recovery, with no recurrence on follow-up.
Bhandari et al. similarly reported SO after TPK with an atypical presentation characterized by predominant posterior segment involvement and minimal anterior chamber reaction. Early corticosteroid therapy led to favorable outcomes, reinforcing the importance of high clinical suspicion in such cases.[8]
Magalhães et al. highlighted the role of imaging, particularly OCT, in demonstrating multilobular serous RD with septations, which may mimic Vogt–Koyanagi–Harada disease and aid in diagnosis.[9]
The temporal profile described by Damico et al. indicates that most cases occur within the first few months after the inciting event, consistent with the early onset observed in our patient and supporting the need for continued surveillance after TPK.[10]
Overall, post-TPK SO may present atypically with predominant posterior involvement. Early recognition and prompt immunosuppressive therapy are essential for achieving favorable visual outcomes.
CONCLUSION
Sympathetic ophthalmia after therapeutic penetrating keratoplasty is an uncommon but vision-threatening complication that may present predominantly with posterior segment involvement. Careful postoperative surveillance of the fellow eye, supported by multimodal imaging, and early systemic immunosuppressive therapy are essential for optimizing visual outcomes.
Author contributions:
SP, MSJ, SAA: Conceptualization, methodology, software, validation, formal analysis, investigation, resources, data curation, writing - original draft, writing - review & editing, visualization, supervision, project administration, and funding acquisition. All authors provided final approval to the work.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understands that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Management and clinical outcome of penetrating keratoplasty for long-term corneal changes in sympathetic ophthalmia. J Ophthalmol. 2011;2011:439025.
- [CrossRef] [PubMed] [Google Scholar]
- Update on sympathetic ophthalmia. Middle East Afr J Ophthalmol. 2012;19:13-21.
- [CrossRef] [PubMed] [Google Scholar]
- An atypical presentation of sympathetic ophthalmia following chemical ocular burns. J Ophthalmic Inflamm Infect. 2023;13:25.
- [CrossRef] [PubMed] [Google Scholar]
- Sympathetic ophthalmia: A comprehensive update. Indian J Ophthalmol. 2022;70:1931-44.
- [CrossRef] [PubMed] [Google Scholar]
- Sympathetic Ophthalmia - EyeWiki. 2026. Available from: https://eyewiki.org/sympathetic_ophthalmia [Last accessed on 2026 Mar 08]
- [Google Scholar]
- Surgery for ocular trauma: Principles and techniques of treatment In: Ryan SJ, Sadda SR, Hinton DR, Schachat AP, Sadda SR, Wilkinson CP, eds. Retina (5th ed). United States: W.B. Saunders; 2013.
- [CrossRef] [Google Scholar]
- Recurrent fungal keratitis following penetrating keratoplasty: An unusual source of infection. Arch Ophthalmol. 2010;128:1490-1.
- [CrossRef] [PubMed] [Google Scholar]
- A rare case of atypical sympathetic ophthalmia post therapeutic keratoplasty. J Ophthalmic Inflamm Infect. 2016;6:34.
- [CrossRef] [PubMed] [Google Scholar]
- Sympathetic ophthalmia after penetrating keratoplasty: A case report evaluated by spectral-domain optical coherence tomography. Retin Cases Brief Rep. 2012;6:11-5.
- [CrossRef] [PubMed] [Google Scholar]
- Sympathetic ophthalmia: A review of the literature. Surv Ophthalmol. 2005;20:191.
- [CrossRef] [PubMed] [Google Scholar]


